Open Philanthropy (organization)

Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza

Retrieved on: 
Tuesday, December 5, 2023
Health, Infectious Diseases, Other Health, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Pandemic, Novo Nordisk Foundation, Global health, Research, Open Philanthropy (organization), PAD, Bill, Epithelium, COVID-19, Therapy, Science, Virus, Infection, Cell, Antiviral drug, Pharmaceutical industry, Vaccine

Exscientia plc (Nasdaq: EXAI) announced today that the Company received a $2.3 million grant from Open Philanthropy, a philanthropic funder with several programs in global health and wellbeing.

Key Points: 
  • Exscientia plc (Nasdaq: EXAI) announced today that the Company received a $2.3 million grant from Open Philanthropy, a philanthropic funder with several programs in global health and wellbeing.
  • Under this grant, Exscientia aims to harness the activation of the host interferon response as a therapeutic approach for pandemic influenza.
  • The grant comes in the context of the wider Pandemic Antiviral Discovery (PAD) initiative.
  • This focus aligns with the company’s ongoing commitment to pandemic preparedness, initiated with support from the Bill & Melinda Gates Foundation in 2021.

Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa

Retrieved on: 
Friday, September 15, 2023
Infection, Patent, Travel, College, Parasitism, Orbital Technologies Commercial Space Station, Drug discovery, Clinical trial, Enzyme, Malaria, African, Research, Fever, Open Philanthropy (organization), Chronic myelogenous leukemia, Pharmacotherapy, Low, Drug resistance, Death, Protein, Rupture, Philip B. Low, Novartis, Developed country, Patient, Philanthropy, Blood, Cancer, Chloroquine, Growth, College of Science (Northeastern University), Disease, Vaccine, Pharmaceutical industry, Chemistry, Purdue University

While studying how malaria propagates in human blood, Low and his research team discovered that the cancer drug therapy imatinib is effective in the treatment of drug-resistant malaria.

Key Points: 
  • While studying how malaria propagates in human blood, Low and his research team discovered that the cancer drug therapy imatinib is effective in the treatment of drug-resistant malaria.
  • Trials in Southeast Asia showed that imatinib, when combined with the customary malaria therapy, clears all malaria parasites from 90% of patients within 48 hours and 100% of patients within three days .
  • Open Philanthropy has awarded Low $600,000 for a larger clinical trial in Southeast Asia to validate his previous trials.
  • His work also receives support from the Purdue Institute for Cancer Research and the Purdue Institute for Drug Discovery .

EQS-News: Evotec receives grant from Open Philanthropy for discovery of RNA-targeting Henipavirus therapeutics

Retrieved on: 
Friday, June 2, 2023
Vaccine, Human, Therapy, Hendra virus, Nipah virus, Frankfurt Stock Exchange, Global health, Research, RNA, Hendra, Open Philanthropy (organization), Henipavirus, ISIN, World Health Organization, R, EVO

Evotec SE (Frankfurt Stock Exchange: EVT, ISIN: DE0005664809; NASDAQ: EVO) today announced that the Company has received a $ 1.7 m grant from Open Philanthropy, a philanthropic funder prioritising global health and wellbeing.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, ISIN: DE0005664809; NASDAQ: EVO) today announced that the Company has received a $ 1.7 m grant from Open Philanthropy, a philanthropic funder prioritising global health and wellbeing.
  • Under the grant, Evotec aims to discover and develop RNA-targeting small molecules as potential first-in-class therapeutics against Henipaviruses.
  • The genus comprises six different established species including Hendra virus and Nipah virus, from which it receives its name.
  • This is the first time that we have been supported by Open Philanthropy and we are very excited about this opportunity.

Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics

Retrieved on: 
Thursday, February 23, 2023
Discovery, Hendra virus, Fatality, Pandemic, Bill, Senior, Nipah virus, Disease, Henipavirus, Drug development, National Center for Advancing Translational Sciences, Virus, Drug discovery, Research, Nipa, Investment, Novo Nordisk Foundation, PAD, Human, RFP, Bill & Melinda Gates Foundation, Infection, COVID-19, Open Philanthropy (organization), Vaccine, Pharmaceutical industry

COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/ -- Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans.

Key Points: 
  • Its purpose is to accelerate the discovery and development of antiviral drugs for future pandemic threats.
  • With equitable access as a core principle of the initiative, PAD is focused on ensuring these interventions are accessible to people in low- and middle-income countries.
  • "Preparing for future pandemics means investing in the discovery of lifesaving interventions before viruses of concern escalate into deadly pandemics and ensuring those tools will be readily available to anyone who needs them."
  • To pave the way for the development of such antiviral drugs, greater knowledge of the henipavirus subfamily is needed.

Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics

Retrieved on: 
Thursday, February 23, 2023
Discovery, Hendra virus, Fatality, Pandemic, Bill, Senior, Nipah virus, Disease, Henipavirus, Drug development, National Center for Advancing Translational Sciences, Virus, Drug discovery, Research, Nipa, Investment, Novo Nordisk Foundation, PAD, Human, RFP, Bill & Melinda Gates Foundation, Infection, COVID-19, Open Philanthropy (organization), Vaccine, Pharmaceutical industry

COPENHAGEN, Denmark, Feb. 23, 2023 /PRNewswire/ -- Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in humans.

Key Points: 
  • Its purpose is to accelerate the discovery and development of antiviral drugs for future pandemic threats.
  • With equitable access as a core principle of the initiative, PAD is focused on ensuring these interventions are accessible to people in low- and middle-income countries.
  • "Preparing for future pandemics means investing in the discovery of lifesaving interventions before viruses of concern escalate into deadly pandemics and ensuring those tools will be readily available to anyone who needs them."
  • To pave the way for the development of such antiviral drugs, greater knowledge of the henipavirus subfamily is needed.

Impossible Foods Introduces Impossible™ Bowls — New Plant-Based Meals in the Frozen Aisle

Retrieved on: 
Friday, September 2, 2022
Retail, Other Consumer, Consumer, Women, Supermarket, Men, Food, Beverage, Howard Hughes Medical Institute, Plant, CEO, Global Investors Summit, Viking Global Investors, Food science, Hope, Fusilli, Impossible, Burrito, UBS, Multimedia, French mother sauces, Cholesterol, Water, Animal, Classic, Pea, Map, Temasek, Khosla Ventures, Horizons Ventures, Chili mac, Stanford University, Meat, GV (company), Biochemistry, Open Philanthropy (organization), Impossible Foods, Fast food, Baking, Sales

California-based Impossible Foods, the fastest-growing plant-based meat company in the U.S., launched its latest food concept in the frozen aisle this week with a new lineup of single-serve frozen entrees: Impossible Bowls delicious plant-based meals ready in minutes.

Key Points: 
  • California-based Impossible Foods, the fastest-growing plant-based meat company in the U.S., launched its latest food concept in the frozen aisle this week with a new lineup of single-serve frozen entrees: Impossible Bowls delicious plant-based meals ready in minutes.
  • Teriyaki Impossible Chicken: Seasoned Impossible Chicken, juicy diced pineapple and peas & carrots tossed in a tangy teriyaki glaze, served over white rice.
  • Chili Mac with Impossible Pork: Classic elbow macaroni tossed with Impossible Pork and a hearty chili-style sauce.
  • Earlier this year, Impossible also introduced frozen Impossible Sausage Patties and Impossible Wild Nuggies in February 2022, followed shortly by Impossible Sausage Links in March 2022.

Impossible Foods Closes $500M in New Funding Amid Record Growth

Retrieved on: 
Tuesday, November 23, 2021
Discount, Variety, Women, Supermarket, Men, Food, Beverage, Health, Consumer, General Health, Retail, Kraken, Viking Global Investors, Climate, Meat, United Arab Emirates, Climate Pledge Arena, Global Investors Summit, Walmart, UBS, Stanford University, Impossible, Temasek, Khosla Ventures, Chicken nugget, Animal, Dairy, GV (company), Howard Hughes Medical Institute, Research, Restaurant, IRI, Box, Climate change, Impossible Foods, Horizons Ventures, Biochemistry, Growth, Open Philanthropy (organization), Renewable energy, Grocery store

California-based Impossible Foods announced today that it has secured approximately $500 million in its latest funding round, led by existing investor Mirae Asset Global Investments with participation from other existing Impossible Foods investors.

Key Points: 
  • California-based Impossible Foods announced today that it has secured approximately $500 million in its latest funding round, led by existing investor Mirae Asset Global Investments with participation from other existing Impossible Foods investors.
  • It is important to us to partner with true innovators like Impossible Foods CEO Pat Brown and support the entire Impossible Foods team as they work to solve one of the most critical challenges facing our planet climate change.
  • Were fortunate to have great investors who believe in our long-term mission, said Impossible Foods Chief Financial Officer David Borecky.
  • California-based Impossible Foods makes delicious, nutritious meat and dairy products from plants with a much smaller environmental footprint than meat from animals.

Impossible Foods Expands in Retail with New Impossible™ Meatballs Made From Plants — Now in a Dedicated Plant-Based Section in Walmart Stores

Retrieved on: 
Tuesday, November 16, 2021
Supermarket, Retail, Environment, Food, Beverage, GV (company), Time, CO2, Open Philanthropy (organization), Biochemistry, Food, Water, Impossible Foods, UBS, Multimedia, Animal, Stanford University, Temasek, Viking Global Investors, National Restaurant Association, Sodium, Khosla Ventures, Howard Hughes Medical Institute, Dairy, Walmart, The New York Times, Global Investors Summit, Cholesterol, Impossible, Meat, Taste, Horizons Ventures, FABI, Grocery store, Fast food

View the full release here: https://www.businesswire.com/news/home/20211116005522/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211116005522/en/
    Impossible Meatballs Made From Plants (Photo: Business Wire)
    Earlier this year, Impossible Foods launched ImpossibleTM Sausage Made From Plants and ImpossibleTM Chicken Nuggets Made From Plants in grocery stores and supermarkets nationwide.
  • The company also dramatically expanded retail availability of its flagship product, ImpossibleTM Burger, which is now available in about 22,000 grocery retail locations.
  • Available at Walmart stores starting this month and coming to additional retailers later this year, the new Impossible Meatballs mark an expansion of Impossible Foods presence at Walmart, which is launching a dedicated plant-based destination in its frozen aisle that will include Impossible products at more than 3,000 locations.
  • The new section will feature Impossible Foods branding and include an array of frozen products made by Impossible Foods, including Impossible Chicken Nuggets, Impossible Sausage in Spicy and Savory flavors, and Impossible Burger patties, as well as the new Impossible Meatballs.

Impossible Foods Accelerates International Expansion with Launches in Australia and New Zealand

Retrieved on: 
Wednesday, November 3, 2021
Retail, Restaurant, Bar, Food, Beverage, Nutrient, Time, Cantine, Horizons Ventures, Biochemistry, Ashby, FABI, Impossible Foods, The New York Times, National Restaurant Association, Heme, Food Standards Australia New Zealand, CO2, UBS, Impossible, B&J, Temasek, Dairy, Khosla Ventures, Food, Stanford University, United Arab Emirates, Iron, Niacin, Butter, IFD, Diet, Water, Multimedia, GV (company), Open Philanthropy (organization), Meat, Viking Global Investors, Animal, FSANZ, Global Investors Summit, Waiheke Island, Howard Hughes Medical Institute, Sale, Life-cycle assessment, ISO, Fast food, Dietary supplement

California-based Impossible Foods has arrived in Australia and New Zealand, marking the companys third and fourth international market launches in 14 months.

Key Points: 
  • California-based Impossible Foods has arrived in Australia and New Zealand, marking the companys third and fourth international market launches in 14 months.
  • Our launches in Australia and New Zealand are another huge step towards bringing delicious, sustainable options to every market in the world, said Dennis Woodside, president of Impossible Foods.
  • To learn more about Impossible Foods launch in Australia and New Zealand, and to find a participating restaurant, please visit https://impossiblefoods.com.au or https://impossiblefoods.nz .
  • Impossible Beef is also available to order via Impossible Foods local importers Beak & Johnston (B&J) in Australia and Integrity Food Distributors (IFD) in New Zealand.

Life insurance organization is on a mission to empower women

Retrieved on: 
Monday, October 11, 2021
Â, National Good Neighbor Day, Program, GLOBE, Growth, Royal Neighbors of America, Woman, CEO, Leadership, Open Philanthropy (organization), Organization

To date, more than $2.5 million has been awarded from this program which serves as the organizations signature womens empowerment program.

Key Points: 
  • To date, more than $2.5 million has been awarded from this program which serves as the organizations signature womens empowerment program.
  • Our Nation of Neighbors award and grant recipients each possess a unique and meaningful purpose, said Cynthia Tidwell, Royal Neighbors President and CEO.
  • Royal Neighbors of America is a unique provider of life insurance and annuities whose mission is to protect women financially and empower them to improve their lives, families, and communities.
  • Royal Neighbors was founded in 1895 as a membership organization by nine pioneering women who recognized the need to insure the lives of women and children.